Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...

Inflammatory Bowel Disease V: Surgical Management

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial.

Cancer cell·2024

Same author

Ischemic Sigmoid Colon Presenting As Hemoperitoneum From an Avulsed Mesocolon During Colonoscopy: A Case Report and Literature Review.

Cureus·2024

Same author

The SAGES masters program presents the 10 seminal articles for laparoscopic sleeve gastrectomy.

Surgical endoscopy·2024

Same author

A Single-Institution 5-Year Retrospective Analysis of Laparoscopic Sleeve Gastrectomy Staple-Line Reinforcement: Bioabsorbable Mesh Versus Oversewing.

Journal of laparoendoscopic & advanced surgical techniques. Part A·2023

Same author

Endoscopic Treatment of Gastroesophageal Reflux Disease.

Advances in surgery·2022

Same author

Increased inflammatory low-density neutrophils in severe obesity and effect of bariatric surgery: Results from case-control and prospective cohort studies.

EBioMedicine·2022

Search research articles

Related Experiment Video

Updated: May 23, 2026

Sleeve Gastrectomy in Mice using Surgical Clips

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

Bariatric surgery significantly improves body proportion.

Thomas Kang¹, James Wooldridge, Laura Periou

¹Department of General Surgery, Ochsner Clinic Foundation, New Orleans LA.

Ochsner Journal

|March 23, 2012

Summary

Bariatric surgery improves body proportion, measured by waist-hip ratio (WHR), alongside weight loss. This enhanced body proportion may independently reduce health risks associated with diabetes and cardiovascular disease.

Keywords:

Bariatric surgery body mass index waist-hip ratio

More Related Videos

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

A Murine Model of Vertical Sleeve Gastrectomy

A Murine Model of Vertical Sleeve Gastrectomy

Published on: December 18, 2017

Related Experiment Videos

Last Updated: May 23, 2026

Sleeve Gastrectomy in Mice using Surgical Clips

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

A Murine Model of Vertical Sleeve Gastrectomy

A Murine Model of Vertical Sleeve Gastrectomy

Published on: December 18, 2017

Area of Science:

Bariatric Surgery
Metabolic Health
Cardiovascular Risk Reduction

Background:

Bariatric surgery is recognized for significant weight loss and improvement in comorbidities.
Body proportion is an independent predictor of diabetes and cardiovascular risk.
This study investigates if bariatric surgery improves body proportion, potentially reducing health risks beyond overall weight loss.

Purpose of the Study:

To evaluate the impact of bariatric surgery on body proportion.
To assess if improvements in body proportion correlate with reduced health risks.
To determine if these changes are independent of overall weight loss.

Main Methods:

168 patients undergoing laparoscopic bariatric surgery were studied.
Data collected included body mass index (BMI), excess weight loss (EWL), and waist-hip ratio (WHR).
Medication status for hypertension, hyperlipidemia, and diabetes was tracked preoperatively and up to 12 months postoperatively.

Main Results:

Mean waist-hip ratio (WHR) significantly decreased from 0.91 preoperatively to 0.86 at 1 year (P < .0001).
At 1-year follow-up, significant percentages of patients discontinued medications: 52% for hypertension, 64% for diabetes, and 56% for hyperlipidemia.
Excess weight loss (EWL) was substantial, reaching 52.48 lbs at 1 year.

Conclusions:

Bariatric surgery significantly improves body proportion (WHR) independent of overall weight loss.
This improvement in body proportion may contribute to decreased health risks.
Further long-term studies are needed to confirm the durability of WHR improvements and their association with cardiovascular events.